Literature DB >> 17331168

Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis.

Hideyuki Kojima1, Shinya Sakurai, Masahito Uemura, Hiroshi Fukui, Hiroyo Morimoto, Yasuhiro Tamagawa.   

Abstract

BACKGROUND: Oxidative stress plays a major role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Mitochondrial abnormality may be associated with the onset and progression of NASH via excessive formation of mitochondrial reactive oxygen species. This study aimed to investigate the role of mitochondrial abnormality in NASH in relation to oxidative stress.
METHODS: Twenty-six patients with NASH, 11 with simple steatosis, and 10 healthy volunteers underwent clinico-pathological analysis. The liver/spleen ratio, an index of the hepatic fat content, was evaluated with computed tomography. Plasma glutathione levels were measured as an antioxidative marker, and the urinary 8-isoprostane levels and 3-nitrotyrosine staining in the liver as an oxidative stress marker. Mitochondrial abnormality was estimated by serum levels of mitochondria aspartate transaminase (mAST) and the mitochondrial staining in the liver.
RESULTS: Urinary 8-isoprostane levels were higher in NASH than in the healthy volunteers, whereas plasma glutathione levels were similar in the 2 groups. In NASH, urinary 8-isoprostane levels positively correlated with alanine transaminase levels and negatively with the liver/spleen ratio. The 3-nitrotyrosine staining was more advanced in simple steatosis and NASH than in the normal liver, but was similar in simple steatosis and NASH. In contrast to the normal mAST levels in the healthy volunteers and simple steatosis, serum mAST levels were elevated in one-fourth of the NASH patients and positively correlated with urinary 8-isoprostane levels in NASH. Most cases of NASH showed diffuse or focal but intense mitochondrial staining in the liver in contrast to scattered staining in simple steatosis.
CONCLUSIONS: Our present study demonstrated that in NASH, the enhanced oxidative stress may be associated with hepatic inflammation and the degree of fat infiltration in the liver. However, simple steatosis and NASH were both exposed to oxidative stress, while NASH alone was associated with mitochondrial abnormality. These findings indicate that mitochondrial abnormality may play a role in the onset and progression of NASH in correlation with oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331168     DOI: 10.1111/j.1530-0277.2006.00288.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  29 in total

1.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

2.  Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease.

Authors:  Hyunjoo Kwon; Kyoungsub Song; Chang Han; Weina Chen; Ying Wang; Srikanta Dash; Kyu Lim; Tong Wu
Journal:  Hepatology       Date:  2015-12-18       Impact factor: 17.425

Review 3.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

4.  Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice.

Authors:  Wing-Kin Syn; Liu Yang; Dian Jung Chiang; Yue Qian; Youngmi Jung; Gamze Karaca; Steve S Choi; Rafal P Witek; Alessia Omenetti; Thiago A Pereira; Anna Mae Diehl
Journal:  Liver Int       Date:  2009-04-20       Impact factor: 5.828

Review 5.  Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Geyza Nogueira de Almeida Armiliato; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-03-27

6.  A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice.

Authors:  Indrani Sinha-Hikim; Amiya P Sinha-Hikim; Ruoqing Shen; Hyun Ju Kim; H Kim; Samuel W French; Nosratola D Vaziri; Nosratola D Vaziri; Albert C Crum; Albert Crum; Tripathi B Rajavashisth; Keith C Norris
Journal:  Exp Mol Pathol       Date:  2011-05-03       Impact factor: 3.362

7.  α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling.

Authors:  Mohammad Kamrul Hasan; Theodore C Friedman; Carl Sims; Desean L Lee; Jorge Espinoza-Derout; Adaku Ume; Victor Chalfant; Martin L Lee; Indrani Sinha-Hikim; Kabirullah Lutfy; Yanjun Liu; Sushil K Mahata; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

8.  IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.

Authors:  Jue Wei; Min Shi; Wei-Qi Wu; Hui Xu; Ting Wang; Na Wang; Jia-Li Ma; Yu-Gang Wang
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

9.  Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.

Authors:  Theodore C Friedman; Indrani Sinha-Hikim; Meher Parveen; Sonia M Najjar; Yanjun Liu; Michael Mangubat; Chang-Sung Shin; Alexei Lyzlov; Rasheed Ivey; Magda Shaheen; Samuel W French; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2012-10-23       Impact factor: 4.736

10.  Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis.

Authors:  Man-Jie Zhu; Li-Juan Sun; Yue-Qin Liu; Yan-Ling Feng; Hai-Tao Tong; Ying-He Hu; Zheng Zhao
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.